These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38244267)

  • 1. Perianesthetic metabolic acidosis is associated with 2% dorzolamide eye drops in dogs that underwent ophthalmic surgery: a retrospective study (2019-2022).
    Lim J; Lee I; Seo K; Son WG; Kang S
    J Am Vet Med Assoc; 2024 Feb; 262(2):1-9. PubMed ID: 38244267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypokalemia and suspected renal tubular acidosis associated with topical carbonic anhydrase inhibitor therapy in a cat.
    Thiessen CE; Tofflemire KL; Makielski KM; Ben-Shlomo G; Whitley RD; Allbaugh RA
    J Vet Emerg Crit Care (San Antonio); 2016 Nov; 26(6):870-874. PubMed ID: 26595765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypokalemia associated with topical administration of dorzolamide 2% ophthalmic solution in cats.
    Czepiel TM; Wasserman NT
    Vet Ophthalmol; 2021 Jan; 24(1):12-19. PubMed ID: 33085174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic acidosis during general anaesthesia: presumed systemic toxicity caused by topical dorzolamide in a dog.
    McFadzean WJ; Murrell J; Donaldson D
    Vet Anaesth Analg; 2018 Nov; 45(6):883-884. PubMed ID: 30301664
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic acidosis and anaemia associated with dorzolamide in a patient with impaired renal function.
    Hoffmanová I; Sánchez D
    Br J Clin Pharmacol; 2018 Apr; 84(4):796-799. PubMed ID: 29333622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs.
    Gelatt KN; MacKay EO
    Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
    Sugrue MF
    J Ocul Pharmacol Ther; 1996; 12(3):363-76. PubMed ID: 8875343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.
    Wilkerson M; Cyrlin M; Lippa EA; Esposito D; Deasy D; Panebianco D; Fazio R; Yablonski M; Shields MB
    Arch Ophthalmol; 1993 Oct; 111(10):1343-50. PubMed ID: 8216014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical dorzolamide and metabolic acidosis in a neonate.
    Morris S; Geh V; Nischal KK; Sahi S; Ahmed MA
    Br J Ophthalmol; 2003 Aug; 87(8):1052-3. PubMed ID: 12881361
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic Acidosis with Ophthalmic Dorzolamide in a Neonate.
    Capino AC; Dannaway DC; Miller JL
    J Pediatr Pharmacol Ther; 2016; 21(3):256-9. PubMed ID: 27453705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of prophylactic topical carbonic anhydrase inhibitors in canine primary closed-angle glaucoma.
    Stavinohova R; Newton JR; Busse C
    J Small Anim Pract; 2015 Nov; 56(11):662-6. PubMed ID: 26334202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratitis in six dogs after topical treatment with carbonic anhydrase inhibitors for glaucoma.
    Beckwith-Cohen B; Bentley E; Gasper DJ; McLellan GJ; Dubielzig RR
    J Am Vet Med Assoc; 2015 Dec; 247(12):1419-26. PubMed ID: 26642138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor.
    Pfeiffer N
    Surv Ophthalmol; 1997; 42(2):137-51. PubMed ID: 9381367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of retinal hemodynamics with the Canon laser blood flowmeter after a single dose of 2% dorzolamide hydrochloride eyedrops.
    Faingold D; Hudson C; Flanagan J; Guan K; Rawji M; Buys YM; Trope GE
    Can J Ophthalmol; 2004 Aug; 39(5):506-10. PubMed ID: 15491034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical drug delivery to the eye: dorzolamide.
    Loftsson T; Jansook P; Stefánsson E
    Acta Ophthalmol; 2012 Nov; 90(7):603-8. PubMed ID: 22269010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dorzolamide hydrochloride on ocular tissues.
    Inoue J; Oka M; Aoyama Y; Kobayashi S; Ueno S; Hada N; Takeda T; Takehana M
    J Ocul Pharmacol Ther; 2004 Feb; 20(1):1-13. PubMed ID: 15006154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs.
    Cawrse MA; Ward DA; Hendrix DV
    Am J Vet Res; 2001 Jun; 62(6):859-63. PubMed ID: 11400841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marginal keratitis: an uncommon form of topical dorzolamide allergy.
    Taguri AH; Khan MA; Sanders R
    Am J Ophthalmol; 2000 Jul; 130(1):120-2. PubMed ID: 11004272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
    Plummer CE; MacKay EO; Gelatt KN
    Vet Ophthalmol; 2006; 9(4):245-9. PubMed ID: 16771760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular hemodynamics and visual field in glaucoma treated with dorzolamide].
    Bernd AS; Pillunat LE; Böhm AG; Schmidt KG; Richard G
    Ophthalmologe; 2001 May; 98(5):451-5. PubMed ID: 11402826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.